MK-0974 (telcagepant)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK-0974 (telcagepant), covering 2014-08-11 to 2014-08-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046) [Phase 2]